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AbstrAct
Objectives To investigate the factors contributing to 
medicine-related problems (MRPs) among patients with 
cardiovascular diseases (CVDs) and/or diabetes in Saudi 
Arabia.
Design Qualitative semistructured interviews were 
conducted. Interviews were audio recorded then 
transcribed into Microsoft Word. The transcribed interviews 
were then imported into the qualitative analysis software 
NVivo where thematic analysis was applied. Thematic 
synthesis was achieved by coding and developing 
subthemes/themes from the findings of the interviews.
setting Five healthcare centres in Najran, Saudi Arabia.
Participants 25 adult patients with diabetes and/or CVDs.
results The study cohort included 16 men and 9 women 
with a median age of 61.8 years (40–85 years). Diabetes 
was the main condition encountered among 23 patients 
and CVDs were reported among 18 patients. Perceived 
factors leading to MRPs were of four types and related 
to: patient-, healthcare system-, clinical (condition-) 
and medicine-related factors. Patient-related factors 
were related to living situation, religious practices, diet/
exercise and patients’ behaviour towards the condition and 
medicines. Healthcare system-related factors comprised 
sources and availability of medicines, ease of access to 
healthcare system and patient satisfaction with healthcare 
providers. Clinical (condition-) related factors associated 
with both the knowledge and control over condition, 
and effects of the condition among medicines intake. 
Medicine-related factors included lack of knowledge about 
medicines and medicine use.
conclusions The results of this study uncovered many 
factors associated with MRPs among patients with CVDs 
and diabetes in Saudi Arabia, especially in reference to 
lifestyle and medicine use. Improving communication 
with healthcare professional alongside the introduction of 
national clinical guidance would mitigate the unwanted 
health complications related to medicine use.
IntrODuctIOn
Medicine-related problem (MRP) is defined 
as ‘an event or circumstance involving drug 
therapy that actually or potentially interfere 
with the desired outcome’.1 Research shows 
that MRPs contribute to a high number of 
morbidities and mortalities worldwide as well 
as an increased healthcare expenditure.2 
MRPs are also responsible for undesirable 
health consequences in patients that often 
result in hospitalisation. Previous published 
systematic reviews and meta-analyses esti-
mated that MRPs accounted for up to 10% 
of total hospitalisation.3–5 MRPs can occur 
at any stage of the medicine use and could 
be affected by many factors related mainly to 
the: condition, patient and/or medicines.3 
Patients with cardiovascular diseases (CVDs) 
and/or diabetes mellitus (DM) are often on 
polypharmacy which increases their suscepti-
bility to MRPs.6–8 
Polypharmacy has been reported as one of 
the major risk factors leading to MRPs in adult 
patients.9 10 Additional risk factors that have 
been reported in the literature include: old 
age, female gender, depression, immobilisa-
tion, cohabitation and lack of education.6 11–15 
However, these factors were mainly extracted 
from quantitative studies, which comprised 
either direct observations or reviewing the 
medical records retrospectively. Hence, a 
limited number of qualitative studies have 
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strengths and limitations of this study
 ► The study explored factors related to patients’ 
behaviour and attitudes towards medicine use in 
diabetes and/or cardiovascular diseases.
 ► The study employed semistructured interviews in 
five different regions within Saudi Arabia, providing 
realistic account for other regional states in the 
Gulf region as they share most demographic 
characteristics.
 ► The outcomes of the study can be integrated in 
future interventions to tackle medicine-related 
problems.
 ► The findings of the study may not be generalised to 
other locations with different populations.
 ► There was no first-hand observational data to 
compare with the interview interpretations.
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explored factors contributing to MRPs from the patients’ 
perspectives.3 Precisely, these studies investigated the rela-
tionship between MRPs and socioeconomic status and 
lifestyle16–28; knowledge regarding medicine and adher-
ence to therapy and knowledge about the condition and 
its management.16 29–35 From the aforementioned studies 
the following factors emerged: patients’ behaviour 
towards healthcare systems/medicines/conditions. Also, 
patients’ beliefs, family history of condition, type of diet, 
lack of exercise, smoking, excess alcohol intake, excess 
caffeine intake and stress.16 29–35 However, it is crucial to 
take into consideration that these factors were extracted 
from studies carried out in only 12 countries, which 
included: Australia,28 Brazil,27 Cameroon,30 Canada,29 
Croatia,25 Ireland,24 Malaysia,31 32 South Africa,22 Spain,32 
Taiwan,34 the UK6 16 17 19 21 26 35 and the USA.18 20 23 Yet, to 
date no study has investigated factors leading to MRPs in 
patients with CVDs and/or DM in Saudi Arabia or even in 
the Middle East.
Therefore, this study aims to explore the potential 
contributory factors leading to MRPs in adult patients 
with CVDs and/or DM in Saudi Arabia.
MethODs
study design
The study used semistructured interviews with adult 
patients who had diabetes and/or CVD. The main aims 
of the interviews were to explore the contributory factors 
that could lead to MRPs. The interview guide included 
core questions for all the participants and allowed flex-
ibility to follow-up further information (online supple-
mentary appendix I).
Patient population
Participants were recruited from five randomly selected 
healthcare centres (HCCs) located at both urban and 
rural areas within Najran region, Saudi Arabia. The 
interviews were conducted between June and July 2014 
in private rooms directly after the patients’ visit to the 
Chronic Disease Clinics in each centre. A purposive 
sampling approach was adopted,36–38 where patients 
recruited were adults aged ≥18 years, who had CVDs and/
or DM (according to the ICD-10 codes; ICD, International 
Classification of Diseases) and gave full verbal consent for 
the interview. Data saturation was reached after the 21st 
interview. However, data collection process was continued 
until organised themes constructed. Patients excluded 
were those who could not communicate and/or did not 
give their consent for any reason.
Participants’ recruitment
Potential eligible participants were identified from the 
existing databases of the HCCs through the diagnosis 
codes for CVDs and DM (ICD-10 codes), assigned to them 
when they were transferred to the HCCs to check-up and 
take their repeated prescriptions once monthly. Before 
contacting the patient to obtain informed consent, the 
patient’s attending physician was contacted for authori-
sation to approach the patient. Once the physician’s 
authorisation was obtained, a trained nurse approached 
each potential participant in order to confirm the study 
eligibility. Thereafter, eligible participants were provided 
with informed consent for the study. Diagnosis was 
confirmed for each patient after they agreed to partici-
pate in the study and gave their consent. Prior to the 
interviews AMAH reconfirmed the consents of patients 
verbally. Participants were also made aware that they could 
withdraw and leave the study at any time they would like 
to. Moreover, the objectives of the study were explained 
to the patients at the beginning of each interview.
Data collection
A total of 25 patients met the study inclusion criteria 
and were interviewed. Semistructured interviews were 
conducted by the researcher (AMAH) at the five HCCs 
(online supplementary appendix I). Each patient was 
interviewed independently. All interviews were audio 
recorded using a Sony voice recordable frequency modu-
lation radio, with the patient’s permission. In addition, 
the researcher took notes during the interview when 
required. For instance, notes were taken for non-verbal 
responses such as smiling, looking sad, feeling angry, 
among others. Each interview started with a demographic 
section to confirm patient’s age, nationality, language, 
marital status, religion and education level. This was 
followed by open questions regarding the patients’ expe-
riences with clinical-related, lifestyle-related and medi-
cine-related factors that may lead to MRPs. Patients were 
made aware that there was no right or wrong answer, and 
hence were encouraged to give their opinions honestly 
and openly. Moreover, when required, probing questions 
were asked to encourage the patients to express their 
views. At the end of each interview, patients were given 
the opportunity to comment and ask questions about the 
topics of the interview. Finally, participants were thanked 
for their contribution to the study and invited to listen 
to the recording if they wished. Each interview lasted 
around 30 min.
translation
The interviews were conducted in Arabic and the notes 
taken during the interviews were also in Arabic. The final 
transcripts of the interviews were translated into English 
by the researcher. To validate the translation, one of the 
research supervisors, who is also bilingual, translated a 
sample of the interviews. Then, any issue was resolved by 
discussion.
The translation of the interview scripts was made using 
a back-translation technique. In this respect, the interview 
scripts were translated by two translators (the researcher 
and one of his supervisors); then, the back-translation 
into English was made by a further two bilingual trans-
lators within the department. This was followed by a 
group discussion between the researcher and the trans-
lators, where the original version was compared with the 
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translated version. Only minor differences were found, 
particularly in the expressions related to the local culture. 
Consequently, appropriate changes to the wordings were 
made in the original version to make it theoretically 
equivalent to the English version.
Data analysis
An ethnographic approach to data analysis was used in 
order to support the interaction between theory, resources 
and methods.39 This was started by reviewing the liter-
ature regarding MRPs among adult patients with CVDs 
and/or DM. The outcomes of the review were discussed 
among the researchers. As a result, the relevant outcomes 
were used in framing the semistructured guide40 and the 
following subjects were included: patient, clinical and life-
style (online supplementary appendix II). Each interview 
was transcribed into Microsoft Word 2007 and labelled 
with each participant’s unique reference code. The tran-
scribed interviews were discussed among researchers to 
enhance the analysis. Then the interviews were imported 
into the qualitative software package NVivo beta for Mac; 
which was used for the coding and extraction of themes 
and subthemes.41 Inductive approach was adopted in 
order to allow themes to develop from open-ended 
questions. Primary coding of data reflected the prob-
lems relating to medicines, and was developed by two 
independent members of the research team. The results 
were compared and any discrepancies were resolved by 
discussion. Similarly, secondary coding was applied to the 
primary categories and provided more details regarding 
the patients’ knowledge and attitude. The coding frame-
work clarified what should be included in each category 
and ensured that the extracted themes were of signifi-
cant to the topic. In order to ensure trustworthiness of 
the coding procedure, coding was undertaken by two 
members of the research team and an additional inde-
pendent member who had not been involved with the 
development of the coding frame.
results
Twenty-five patients (of a total of 40 invited to take part) 
participated in the study (response rate 62.5%) at five 
HCCs in Najran, Saudi Arabia. The aforementioned 
patients included 16 adult men and 9 women, with a 
median age of 61.8 years (40–85 years). The majority 
of the patients were Saudis (n=20), whereas fewer were 
Yemenis (n=3), Egyptian (n=1) and Indian (n=1). All 
of the patients were Muslims. The marital status of the 
included patients was as follows: 18 were married, 1 
widow, 3 divorced and 3 unknown as they preferred not to 
say. Regarding the educational level, 13 patients were illit-
erate, 3 could read and write without a certificate, 8 had 
a school certificate and only 1 had a bachelor’s degree. 
All of the patients spoke Arabic and one was bilingual 
(Arabic and Urdu).
Patients were identified whether they had MRPs at a 
screening interview. In this respect, patients with MRPs 
were more likely to agree to be interviewed. From the 
participant experience, four groups of risk factors leading 
to MRPs and included: patient-, healthcare system-, clin-
ical (condition-) and medicine-related factors (table 1).
Patient-related factors
Sociodemographic factors
Regarding the patients’ conditions, DM was the main 
condition encountered by 23 patients. CVDs were also 
reported in 16 patients including hypertension (HTN), 
hypercholesterolaemia and ischaemic heart disease. On 
the other hand, two patients suffered from CVDs only. Also, 
comorbidities were reported alongside the main condi-
tions in 12 patients and were mainly abdominal distur-
bances, anaemia, neuropathy and hypercholesterolaemia.
The most common reported medicinal classes were 
antihypertensive and heart medicines, whereas, for DM 
were oral hypoglycaemic agents and insulin. Unexpect-
edly polypharmacy was not an issue among participants. 
Hence, the average number of medicines taken per 
patient was 3.5 (range 2–6).
Three social factors emerged from the interviews, and 
were: number of people living at home, help at home with 
medicines and religious practices interfering with medi-
cine use and adherence to medicine regimen. None of the 
patients was living alone, and the mean number of people 
living at home with patients was seven (range 2–13). In 
this respect, family members often helped patients with 
their medicine intake as one patient responded to a ques-
tion if he takes his medicine by himself:
No, my children do. I did not know how to use it 
myself.
They tried to teach me in the dispensary but I failed 
to learn.
My children are educated;
one of them is a pharmacist and gives it to me (Patient 
15).
Only six patients reported that they use the medicines 
by themselves. Yet, the patients’ medicine intake was 
affected by religious practices such as pilgrimage and 
fasting where patients admitted missing/delaying medi-
cines until breaking their fasting. One patient considered 
pilgrimage as an alternative cure to their condition and 
did not take the medicines:
I never take it (medicine) during Hajj or Omrah
because walking during Hajj and Omrah relieves 
me…
so I don’t need to take it (Patient 1).
Lifestyle factors
Lifestyle factors contributing to MRPs among participants 
were body weight/body mass index, poor diet, smoking 
and lack of physical activity. A total of nine patients 
reported obesity or overweight; whereas, 11 did not know 
their body weight. On the other hand, only five patients 
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Table 1 Themes and subthemes emerging from the interviews
Category Themes/subthemes identified within this category
Patient-related factors Sociodemographic factors
Demographic factors
 ► Overweight/obesity
 ► Blood glucose level
 ► Blood pressure
 ► Smoking
Social factors
 ► Number of people at home
 ► Help at home with medicines
 ► Religious practices such as fasting and pilgrimage interfering with taking medicines
Lifestyle-related factors
Physical activity
Patients lifestyle in relation to exercise
 ► Daily exercise
 ► Lack of time for exercise
 ► Lack of facilities for exercise
 ► No motivation towards exercise
 ► Perception of daily activities as exercise
 ► Social/cultural restrictions
Diet
 ► Regular/irregular meals
 ► Overeating due to food craving or social gatherings
 ► Awareness of diet importance
 ► Types and availability of meals
 ► Smoking
Healthcare system-related factors
Healthcare system
 ► Ease of access to healthcare system
 ► Patient satisfaction with healthcare system
 ► Availability of medicines
 ► Affordability of healthcare service (type of provider)
Relationship with healthcare providers
 ► Education time and quality
 ► Counselling and support
 ► Lack of trust in healthcare professionals
 ► Understanding of instructions from healthcare providers
 ► Communication barriers
Clinical (condition-) related factors Knowledge about condition
 ► Knowledge about CVD/DM
 ► Denial of condition considering it a lifestyle factor
 ► Underestimating the severity of the condition
 ► Fear of condition
 ► Perception that the condition is from God
 ► Perception of experience with the disease
Effects of condition
 ► Social life
 ► Diet
 ► Medicine intake
Control over condition/symptoms
 ► Management of condition
 ► Fluctuation of blood pressure/blood glucose level
 ► Control over blood pressure/blood glucose level
 ► Fear of hypoglycaemia/hypertension
Comorbidities
 ► Number of comorbidities
 ► Unacceptance of comorbidities
Medicine-related factors Knowledge about medicines
 ► Knowledge about medicine effects and side effects
 ► Knowledge of medicine names and doses
 ► Fear of side effects
 ► Belief in alternative and natural therapies (fear of medicines being toxic chemicals)
 ► Belief that exercise can control the condition (replace medicines)
 ► Belief that diet can control the condition (replace medicines)
Medicine intake
 ► Number of medicines
 ► Ease of use of medicines
 ► Difficulty in medicine intake
 ► Forgetfulness to take medicines
 ► Follow-up of instructions in relation to medicine intake
 ► Refusal to take medicines
 ► Not taking medicines because of fasting
CVD, cardiovascular disease; DM, diabetes mellitus.
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claimed healthy weight. Despite the reported obesity/
overweight, the majority of patients (n=20) reported 
eating healthy and balanced diet two to three times a 
day. Yet, 13 of these patients were smokers or ex-smokers. 
When asked about their physical activities, 11 patients 
had misconception regarding exercises. They perceived 
certain activities as exercise such as walking to work, 
working in a car workshop/market. Additionally, three 
patients could not exercise due to physical incapability 
and four due to lack of time. In those patients, physical 
inability caused fluctuations in the glucose/blood pres-
sure levels which in turn affected the effective condition 
control. In many of these cases doctors found it very chal-
lenging to prescribe the accurate dose and maintain it for 
long term.
Patients’ behaviour towards their condition and medicines
Various contributory factors relating to conditions 
and medicines were identified mainly where patients’ 
behaviour towards the condition and medicine intake will 
enable them gain more control over their conditions. Six 
interviewees declared adjusting their medicine doses and 
modalities of intake according to: condition, nutrition 
(food intake), blood sugar level and condition improve-
ment (less diabetic complications). Likewise, patients 
acknowledged control over their conditions mainly 
relating to increased blood sugar level or blood pressure. 
Hence, patients with diabetes claimed to have control 
over their blood sugar level. They indicated measuring 
their glucose level at home (with their own devices) and 
adjusting it with regulating their food consumption. Yet, if 
the level was high, they either stayed at home and rested, 
or adjusted the dose of insulin/oral hypoglycaemic 
agent. A similar attitude was stated regarding uncon-
trolled blood pressure. In all cases (diabetes and HTN) 
patients reported that they controlled their health prob-
lems and did not report them to the healthcare system. 
Hence, active decision-making was an important factor in 
prompting adherence to medicines.
healthcare system-related factors
Additional emerging factors that affected adherence 
and hence caused MRPs were related to the health-
care system, namely: the sources and availability of 
medicines, ease of accessibility and patient satisfaction 
with the healthcare providers. Governmental hospi-
tals/dispensaries were the main source of medicines. 
However, in a very few cases (n=4) if medicines were not 
available in governmental hospitals, community phar-
macies were the second option. Thus, 21 patients used 
government dispensaries to access their medicines, 
whereas three patients took their medicines only from 
community pharmacies, and one has had his medi-
cines delivered to his home from a private hospital. 
Community pharmacies were accessed only when medi-
cines (such as multivitamins) were not available in the 
governmental dispensaries. Consequently, the ease of 
access to medicines and healthcare system was attained 
by a few limitations being: waiting time for prescrip-
tion processing, the limited opening hours of the 
chronic conditions’ clinic. Yet, patients did not relate 
the long waiting time to satisfaction with the quality of 
the provided healthcare services. Thus, the majority 
of patients (n=21) were satisfied with the quality of 
the offered healthcare services. Only four patients 
complained that HCCs were crowded with patients 
with no predetermined appointments and the limited 
access times (ie, the clinic runs only once a week). They 
further complained that healthcare providers did not 
provide enough information for patients. Additionally, 
major concerns arose regarding lack of communica-
tion and decreased contact time with the healthcare 
professionals. The aforementioned concerns negatively 
influenced the patients’ relationship with healthcare 
providers. Thus, the patients reported their comments 
on counselling and support, communication barriers, 
understanding the language, education quality and time 
and lack of trust towards the healthcare professionals:
No, they do not understand me. They never tell me 
anything.
They write down my medicine on a piece of paper 
to get them but they never explained anything. The 
doctor is always busy and thinks that we understand 
his writing (Patient 22).
Fewer patients were satisfied with the service provided 
by the healthcare professionals and appreciated their 
advice. However, some of them did not follow the given 
advice or did not understand them initially.
condition-related factors
Principally, not following the healthcare professionals’ 
advice often resulted in patients’ lack of knowledge 
regarding their conditions which then affected their 
medicines’ intake. When asked about their conditions, 
most of the patients stated that they had more experi-
ence and knowledge about their disease(s) (CVDs and 
DM) than healthcare professionals. Patients believed 
they could manage their conditions without need to the 
healthcare professionals:
Diabetic and blood pressure patient knows how to 
treat himself (Patient 21).
This was partly because of the decreased contact time 
and lack of communication with the healthcare profes-
sionals. Consequently, patients with both CVDs and 
diabetes lacked control over their conditions. Specifi-
cally, patients with diabetes had fluctuating blood glucose 
levels between 70 mg/dL and 350 mg/dL (normal level 
≤126 mg/dL). Patients attributed the fluctuation in their 
blood glucose level to: carelessness, the amount and type 
of the food they have and ineffectiveness of the provided 
treatment. Similarly, hypertensive patients did not show 
control over their fluctuating blood pressure; which they 
attributed to the life stress.
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‘My blood pressure level goes high when I am
nervous but most of the time it is fine’ (Patient 16).
This poor management of the conditions led to regular 
changes in their medicines and doses by their doctors.
Medicine-related factors
The lack of knowledge regarding the medicines and ideal 
medicine use as well as the regular changing of medicine 
doses have led in many cases to poor management of the 
condition. Only one patient could identify the names and 
shapes of medicines/containers. Similarly, they could not 
tell the effects of each medicine and their knowledge was 
limited to the general indication of them (such as CVDs 
or DM). A very few patients (n=4) knew the side effects 
of their medicines. Other patients had a misconception 
regarding side effects of medicines. Thus, one patient 
believed that insulin completely destroys the body.
I totally refused to use insulin and I take tablets 
instead, although the doctor has always been advising 
me to take insulin, but one of my relatives says that it 
totally destroys the pancreas. With tabs, I take 500 mg 
after meals and 5 mg before breakfast and dinner’ 
(Patient 1).
Moreover, three patients believed that diet and exercise 
could cure DM rather than using medicines to manage it.
Patients also relied on family members in taking medi-
cines at certain time periods. A very few patients (n=3) 
reported missing doses. However, during the fasting times 
the whole treating regimen is being changed, which often 
affected patients’ adherence to their medicines. Patients 
described their adherence by expressions like: ‘regularly’, 
‘ordinarily’, ‘taking them as prescribed’, ‘everywhere’ 
and ‘all the time including when travelling’.
The variability in the medicine intake’s pattern did not 
affect the effectiveness of the medicine regimen from the 
patients’ perspective. Hence, most patients were satisfied 
with the treatment. Only few issues were encountered 
with patients and included: not feeling relieved, losing 
consciousness, appetite suppression, nausea and craving 
for food. This led in some cases to non-adherence to the 
regimen. In this respect, patients refused to take their 
medicines because they were unsatisfied with the treat-
ment, felt irritated after taking medicines, being ill, being 
lazy, or had a preference of tablets over injection.
DIscussIOn
To the best of our knowledge, this is the first qualitative 
study conducted regarding to explore the potential risk 
factors leading MRPs in adult patients with CVDs and 
diabetes in Saudi Arabia from the patients’ perspectives 
and practices. In this respect, the findings of this study 
have enabled richer understanding of the main risk 
factors relating to patient, healthcare, clinical and medi-
cines which may lead to MRPs.
Although similar risk factors were reported in other 
countries, patients in this study showed divergent contrib-
utory risk factors leading to MRPs. For instance, unlike 
previous studies6 9 10 the patients in this study were with 
multiple comorbidities but were not on polypharmacy 
with an average of only 3–4 medicines. This could be 
attributed to the lack of national clinical guidance which 
have been used in the developed countries as preventive 
measures.42 43 Other social factors that were specific to the 
interviewed cohort were the patients’ living situation and 
religious practices. The patients’ dependant living situa-
tion made them rely on family members to get help with 
medicines; and this in turns led to MRPs as highlighted 
in previous studies.21 Moreover, patients’ religious prac-
tices including hajj and Omrah had a significant impact 
on delay in medicines intake and/or missing doses. This 
confirmed data from previous research that examined 
the effect of religion on MRPs among Muslim patients in 
the UK.16 19 21
Furthermore, lifestyle risk factors including diet, exer-
cise and smoking showed to have a negative impact on 
the patients’ medicine use, which is consistent with the 
findings from other studies that investigated these issues 
in different parts of the world.16–27 29 34 Patients showed 
misconception in relation to exercise; where they consid-
ered walking to work as exercise. Other patients could not 
exercise due to lack of time, age, stress and/or disease. 
Poor diet also was a more prominent issue in this study 
when compared with other studies in different coun-
tries.16–23 26 31 Hence, patients in this study showed frus-
tration from being overweight and expressed tiredness. 
Moreover, language was an issue, which made it diffi-
cult for patients to understand healthcare professionals. 
This was encountered in similar studies conducted with 
ethnic minorities in the UK who did not speak English 
well.16 17 19 21 The majority of the healthcare team in Saudi 
Arabia was composed of expatriates who did not speak or 
spoke little Arabic.
Subsequently, lack of communication with the health-
care teams influenced the patients’ satisfaction with the 
healthcare system. That was shown through the patients’ 
failure to apply the instructions and recommendations 
provided regarding the management of their condi-
tions. Previous research confirmed that patients who did 
not understand doctors claimed that they did not get 
enough information regarding their disease and medi-
cines.16 17 24 31 35 This was exacerbated by the short consul-
tation time with healthcare professionals. The absence 
of a national patient safety agency in Saudi Arabia that 
assesses the quality of the provided services could weaken 
the culture of accountability among healthcare profes-
sionals to follow the good practice rules.
All the aforementioned barriers led to patients’ lack of 
control over their condition(s) and the subsequent unde-
sirable complications. It is noteworthy that patients with 
CVDs and diabetes from many countries showed limited 
knowledge about their conditions, their nature and the 
symptoms associated with it26 28 29 32 33 which adversely 
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affect the management process. Similarly, patients 
revealed limited knowledge regarding medicines’ mode 
of action, effects and side effects despite their ability to 
identify the class of medicine that they are using. In most 
cases, patients counted on family and friends regarding 
these significant issues. This lack of knowledge about 
the condition resulted in lack of control over it and its 
complications. Subsequently, patients did not take their 
medicines as required which in many occasions resulted 
in treatment ineffectiveness. For instance, patients 
reported fluctuated blood pressure and blood sugar 
levels which they adjusted by changing medicine doses or 
food intake without referring to healthcare professionals. 
This could explain their high level of satisfaction with 
the healthcare system; but low to moderate level of satis-
faction with healthcare professionals. Additional factors 
affecting their medicine use included: polypharmacy, 
religious duties (pilgrimage and fasting) and fear of side 
effects. The latter findings were consistent with studies 
conducted with Muslim population in the UK, where reli-
gious duties implicated MRPs.17 19 21
strengths and weaknesses
This study uncovered many risk factors relating to MRPs 
that can be incorporated into future screening tools to 
predict and identify MRPs. There is very little research 
regarding patients’ views in Saudi Arabia so the study was 
timely in informing about patients’ perspectives of factors 
relating MRPs. The study was limited to patients with 
CVDs and/or DM and may not be generalisable to patients 
with other long-term conditions. Due to the qualitative 
nature of the study, the interpretation of semistructured 
interviews could be subjective; hence, caution should be 
applied in interpretation. However, this was minimised by 
using the interview guide consistently during the inter-
viewing process and validating the interview transcripts.
Implication for clinicians and policy makers
The burden of non-communicable diseases (such as 
CVDs and DM) has been increasing over the last few years 
in Saudi Arabia. Exploring factors contributing to MRPs 
from patients’ statements assist in reducing the numbers 
of unnecessary/unplanned hospital admission. This study 
acknowledged the most important factors contributing to 
MRPs particularly those relating to patients’ behaviour. 
The findings of the research have clear implications 
for practice and policy that are also applicable to other 
regional states in the Gulf region that share most of the 
demographic and practice characteristics.
cOnclusIOns
The findings of this study addressed a gap in the litera-
ture relating to the risk factors leading to MRPs among 
patients with CVDs and diabetes in Saudi Arabia using a 
qualitative approach. These factors were mainly attributed 
to the insufficient support provided for patients through 
the healthcare professionals and subsequently deficiency 
of knowledge about the condition(s) and medicines 
among patients. Additionally, it is evident that an intro-
duction of a national clinical guidance would help 
managing patients with CVDs and DM to achieve favour-
able outcomes. This guidance should take into account 
patients’ perceptions and practices towards their condi-
tion(s), lifestyle and medicines.
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